Meeting
2021 ASCO Annual Meeting
Impact of KRAS mutational status on outcomes in patients with pancreatic cancer (PDAC).
Authors
Lucy Xiaolu Ma
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
Lucy Xiaolu Ma , Gun Ho Jang , Amy Zhang , Robert Edward Denroche , Anna Dodd , Stephanie Ramotar , Shawn Hutchinson , Yifan Wang , Mustapha Tehfe , Ravi Ramjeesingh , James Joseph Biagi , Bernard Lam , Julie Wilson , Faiyaz Notta , Sandra Fischer , Robert C Grant , George Zogopoulos , Steven Gallinger , Jennifer J. Knox , Grainne M. O'Kane
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4142)
DOI
10.1200/JCO.2021.39.15_suppl.4142
Abstract #
4142
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco
Poster
2020 ASCO Virtual Scientific Program
Enrichment of alterations in targetable molecular pathways in KRAS wild-type (WT) pancreatic cancer (PC).
First Author: Philip Agop Philip
Poster
2019 ASCO Annual Meeting
Actionable coalterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.
First Author: Arielle Lutterman Heeke
Poster
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in “pan-negative” lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history.
First Author: Alexander E. Drilon